Hotchkis & Wiley Capital Management
ANIP icon

Hotchkis & Wiley Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.39M Buy
83,050
+8,270
+11% +$645K 0.02% 348
2025
Q4 		$5.9M Buy
74,780
+320
+0.4% +$27.7K 0.02% 379
2025
Q3 		$6.82M Sell
74,460
-12,150
-14% -$991K 0.02% 326
2025
Q2 		$5.65M Sell
86,610
-21,990
-20% -$1.43M 0.02% 380
2025
Q1 		$7.27M Buy
108,600
+51,420
+90% +$3.07M 0.02% 296
2024
Q4 		$3.16M Buy
57,180
+5,100
+10% +$293K 0.01% 438
2024
Q3 		$3.11M Buy
+52,080
New +$3.18M 0.01% 444

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return